Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04548635 · ClinicalTrials.gov registry record · Phase 2
VR for Burn Dressing Changes at Home
A Phase 2 study of Acute Pain and Burns, sponsored by Nationwide Children's Hospital.
- Completed
- Registry status
- Phase 2
- Development phase
- 36
- Enrollment target
- 1
- Study location
NCT04548635: Completed Phase 2 study of Acute Pain and Burns, sponsored by Nationwide Children's Hospital.
NCT04548635 is a Phase 2 study of Acute Pain and Burns that has completed, run by Nationwide Children's Hospital. The registered enrollment target is 36 participants, below the 267-participant average among 50 other Acute Pain trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04548635, a Phase 2 study of Acute Pain and Burns, has completed, sponsored by Nationwide Children's Hospital.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 36 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will evaluate the impact of our smartphone-based Virtual Reality Pain Alleviation Tool (VR-PAT) during the repeated at-home burn dressing changes of children (5-17 years) with a burn injury in comparison with a control group of children with a burn injury who will not use VR-PAT during at-home burn dressing changes. We hypothesize that children using VR-PAT will report less pain during their dressing changes.
Primary Outcome
1-10 rating scale (self-reported and caregiver-reported), 1(min)-10(max), with higher score indicating worse outcome.
Conditions Studied
Interventions
- DEVICE VR-PAT
Study Locations (1)
Ohio
- Nationwide Children's Hospital - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2019-09-05 |
| Est. Completion | 2021-06-18 |
| Phase | Phase 2 |
What the finished NCT04548635 record still lists
NCT04548635 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 36 participants, a relatively small participant target, below the 267-participant average among 50 other Acute Pain trials with a reported enrollment target (87% lower).
The record links to 3 conditions, with Acute Pain appearing as the primary indexed condition, and to 1 intervention - of which VR-PAT is the first listed.
NCT04548635 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT04548635 about?
NCT04548635 is a clinical study titled "VR for Burn Dressing Changes at Home". This study will evaluate the impact of our smartphone-based Virtual Reality Pain Alleviation Tool (VR-PAT) during the repeated at-home burn dressing changes of children (5-17 years) with a burn injury in comparison with a control group of children with a burn injury who will not use VR-PAT during at...
What is the current status of trial NCT04548635?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 36 participants. The study started on 2019-09-05. Estimated completion is 2021-06-18.
What conditions does trial NCT04548635 study?
This clinical trial studies the following conditions: Acute Pain, Burns, Procedural Pain.
What interventions are being tested in trial NCT04548635?
The interventions under investigation include: VR-PAT (DEVICE).
Who is sponsoring clinical trial NCT04548635?
This trial is sponsored by Nationwide Children's Hospital, which has 188 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04548635 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04548635's enrollment target sits among peer trials
36 43rd of 50 higher than 8 of 50 other Acute Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Acute Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Reducing Pain From Wisdom Molar Extractions
RECRUITING · Phase 2
-
Twin Block, Pain Medications and Third Molar Extractions
RECRUITING · Phase 2
-
Study of Wafermine™ for Post-bunionectomy or Abdominoplasty Pain
COMPLETED · Phase 2
-
Liposome Bupivacaine Interscalene Total Shoulder
COMPLETED · Phase 2
-
Acetaminophen Versus IV Hydromorphone for Pain in the Elderly in the ED
COMPLETED · Phase 2
-
Assessment of PF614 Effects on Experimental Pain in the Cold Pressure Test (PF614-201)
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00929006 · 36 participants · Early Phase 1
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
- NCT01891318 · 36 participants · Phase 1
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
- NCT02291848 · 36 participants · Phase 1
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
- NCT02366819 · 36 participants · Phase 4
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI